Cargando…
Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago
INTRODUCTION: The aim of this study was to evaluate response and drug survival of biologic therapy in patients with moderate to severe plaque-type psoriasis who initiated biologic therapy at least 10 years ago, in a real-world setting. METHODS: This was an observational retrospective follow-up study...
Autores principales: | Elberdín, Laida, Fernández-Torres, Rosa M., Paradela, Sabela, Mateos, María, Blanco, Eva, Balboa-Barreiro, Vanesa, Gómez-Besteiro, María I., Outeda, Maria, Martín-Herranz, Isabel, Fonseca, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941069/ https://www.ncbi.nlm.nih.gov/pubmed/35226302 http://dx.doi.org/10.1007/s13555-022-00693-2 |
Ejemplares similares
-
Real-world use of ustekinumab therapeutic drug monitoring in moderate to severe psoriasis
por: Elberdín, Laida, et al.
Publicado: (2022) -
BIOLOGICAL THERAPY OF PSORIASIS
por: Sivamani, Raja K, et al.
Publicado: (2010) -
Pharmacogenetics Update on Biologic Therapy in Psoriasis
por: Muñoz-Aceituno, Ester, et al.
Publicado: (2020) -
Biological therapies in moderate and severe
psoriasis: perspectives and certainties
por: Constantin, MM, et al.
Publicado: (2014) -
COVID, Biologics, and Psoriasis Therapy
por: Elston, Dirk M.
Publicado: (2020)